Evidence map›Paper›PMID 38619840›Full record

Trial reportJAMA network open2024

AI-Generated Draft Replies Integrated Into Health Records and Physicians' Electronic Communication.

Ming Tai-Seale, Sally L Baxter, Florin Vaida, Amanda Walker, Amy M Sitapati, Chad Osborne, Joseph Diaz, Nimit Desai, Sophie Webb, Gregory Polston and 12 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in JAMA network open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Trial
  5. Trial
  6. From patient notes to prognostication: The revolutionary potential of event-based foundation models in orthopaedics.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. The potential of artificial intelligence in clinical trials.European journal of clinical investigation · 2026
    Review
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Ming Tai-SealeDepartment of Family Medicine, University of California San Diego School of Medicine, La Jolla.
Sally L BaxterDepartment of Medicine, University of California San Diego School of Medicine, La Jolla.
Florin VaidaDivision of Biostatistics, University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Science, La Jolla.
Amanda WalkerDepartment of Family Medicine, University of California San Diego School of Medicine, La Jolla.
Amy M SitapatiDepartment of Medicine, University of California San Diego School of Medicine, La Jolla.
Chad OsborneDepartment of Family Medicine, University of California San Diego School of Medicine, La Jolla.
Joseph DiazDepartment of Medicine, University of California San Diego School of Medicine, La Jolla.
Nimit DesaiUniversity of California San Diego School of Medicine, La Jolla.
Sophie WebbDepartment of Family Medicine, University of California San Diego School of Medicine, La Jolla.
Gregory PolstonDepartment of Anesthesiology, University of California San Diego School of Medicine, La Jolla.
Teresa HelstenDepartment of Medicine, University of California San Diego School of Medicine, La Jolla.
Erin GrossDepartment of Obstetrics and Gynecology, University of California San Diego School of Medicine, La Jolla.
Jessica ThackaberryDepartment of Psychiatry, University of California San Diego School of Medicine, La Jolla.
Ammar MandviDepartment of Family Medicine, University of California San Diego School of Medicine, La Jolla.
Dustin LillieDepartment of Family Medicine, University of California San Diego School of Medicine, La Jolla.
Steve LiDepartment of Medicine, University of California San Diego School of Medicine, La Jolla.
Geneen GinDepartment of Family Medicine, University of California San Diego School of Medicine, La Jolla.
Suraj AcharDepartment of Family Medicine, University of California San Diego School of Medicine, La Jolla.
Heather HofflichDepartment of Medicine, University of California San Diego School of Medicine, La Jolla.
Christopher SharpDepartment of Medicine, Stanford School of Medicine, Stanford, California.
Marlene MillenDepartment of Medicine, University of California San Diego School of Medicine, La Jolla.
Christopher A LonghurstDepartment of Medicine, University of California San Diego School of Medicine, La Jolla.

Funding

UCSD Center for Learning Health Systems ScienceP30HS029770 · AHRQ · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HOGARTH, MICHAEL A · 2024 to 2025
$2.0M
AHRQ HHS P30 HS029770
6 · The paper itself

Abstract

Importance: Timely tests are warranted to assess the association between generative artificial intelligence (GenAI) use and physicians' work efforts. Objective: To investigate the association between GenAI-drafted replies for patient messages and physician time spent on answering messages and the length of replies. Design, Setting, and Participants: Randomized waiting list quality improvement (QI) study from June to August 2023 in an academic health system. Primary care physicians were randomized to an immediate activation group and a delayed activation group. Data were analyzed from August to November 2023. Exposure: Access to GenAI-drafted replies for patient messages. Main Outcomes and Measures: Time spent (1) reading messages, (2) replying to messages, (3) length of replies, and (4) physician likelihood to recommend GenAI drafts. The a priori hypothesis was that GenAI drafts would be associated with less physician time spent reading and replying to messages. A mixed-effects model was used. Results: Fifty-two physicians participated in this QI study, with 25 randomized to the immediate activation group and 27 randomized to the delayed activation group. A contemporary control group included 70 physicians. There were 18 female participants (72.0%) in the immediate group and 17 female participants (63.0%) in the delayed group; the median age range was 35-44 years in the immediate group and 45-54 years in the delayed group. The median (IQR) time spent reading messages in the immediate group was 26 (11-69) seconds at baseline, 31 (15-70) seconds 3 weeks after entry to the intervention, and 31 (14-70) seconds 6 weeks after entry. The delayed group's median (IQR) read time was 25 (10-67) seconds at baseline, 29 (11-77) seconds during the 3-week waiting period, and 32 (15-72) seconds 3 weeks after entry to the intervention. The contemporary control group's median (IQR) read times were 21 (9-54), 22 (9-63), and 23 (9-60) seconds in corresponding periods. The estimated association of GenAI was a 21.8% increase in read time (95% CI, 5.2% to 41.0%; P = .008), a -5.9% change in reply time (95% CI, -16.6% to 6.2%; P = .33), and a 17.9% increase in reply length (95% CI, 10.1% to 26.2%; P < .001). Participants recognized GenAI's value and suggested areas for improvement. Conclusions and Relevance: In this QI study, GenAI-drafted replies were associated with significantly increased read time, no change in reply time, significantly increased reply length, and some perceived benefits. Rigorous empirical tests are necessary to further examine GenAI's performance. Future studies should examine patient experience and compare multiple GenAIs, including those with medical training.

Indexed as

Artificial IntelligencePhysiciansAdultCommunicationElectronicsFemaleHumansMaleMedical Records Systems, ComputerizedMiddle Aged

Identifiers

PMID38619840
PMCPMC11019394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.